The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical utility of serum miRNAs for the prediction and early detection of recurrence in melanoma patients.
Nathaniel H. Fleming
No relevant relationships to disclose
Ines Esteves Domingues Pires Da Silva
No relevant relationships to disclose
Eleazar Vega-Saenz de Miera
No relevant relationships to disclose
Bobbi G. Brady
No relevant relationships to disclose
Sung Won Han
No relevant relationships to disclose
Douglas Hanniford
No relevant relationships to disclose
Jinhua Wang
No relevant relationships to disclose
Richard L. Shapiro
No relevant relationships to disclose
Eva Hernando-Monge
No relevant relationships to disclose
Judy Zhong
No relevant relationships to disclose
Iman Osman
No relevant relationships to disclose